Avalon Healthcare Solutions Ranks No. 2 on the inaugural 2020 Inc. 5000 Series: Florida With Two-Year Revenue Growth of 3,764%

NEW YORK, March 18, 2020 /PRNewswire/ -- Inc. magazine today revealed that Avalon Healthcare Solutions is No. 2 on its inaugural Inc. 5000 Series: Florida list, the most prestigious ranking of the fastest-growing Florida-based private companies. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the Florida economy's most dynamic segment—its independent small businesses.

"We are thrilled that Avalon is recognized in the inaugural Inc. 5000 Series: Florida list," said Dr. Bill Kerr, Chief Executive Officer.  "Avalon's growth illustrates the confidence our customers have that we deliver on the triple aim in healthcare of improved cost, quality, and access."

The companies on this list show stunning rates of growth across all industries in Florida. Between 2016 and 2018, these 250 private companies had an average growth rate of 302 percent and, in 2018 alone, they employed more than 56,000 people and added $12.6 billion to the Florida economy. Companies based in the Tampa, Miami, and Naples metro areas brought in the highest revenue overall.

Complete results of the Inc. 5000 Series: Florida, including company profiles and an interactive database that can be sorted by industry, metro area, and other criteria, can be found at inc.com/inc5000-series-florida-2020 starting March 18, 2020.

"The companies on this list demonstrate just how much the small-business sector impacts Florida's economy," says Inc. editor in chief Scott Omelianuk. "Across every single industry, these businesses have posted revenue and growth rates that are beyond impressive, further proving the tenacity of their founders and CEOs."

Avalon Healthcare Solutions is a healthcare information technology company focused on medical benefit management. Avalon currently provides two modules: a comprehensive laboratory program to facilitate the management of all outpatient laboratory services, across all providers, and a medical specialty drug clinical claims editing module. Both drive considerable savings for health plans and individuals by automating existing plan policy adherence. In addition, an independent Clinical Advisory Board has developed a suite of evidence-based laboratory policies addressing all lab testing categories. For more information about Avalon, please visit www.avalonhcs.com.

More about Inc. and the Inc. 5000 Regional Series

Methodology

The 2020 Inc. 5000 Regional Series is ranked according to percentage revenue growth when comparing 2016 and 2018. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2018. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2018 is $1 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

SOURCE Avalon Healthcare Solutions